GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (NAS:SMLR) » Definitions » Beneish M-Score

Semler Scientific (Semler Scientific) Beneish M-Score : -2.91 (As of May. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Semler Scientific Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Semler Scientific's Beneish M-Score or its related term are showing as below:

SMLR' s Beneish M-Score Range Over the Past 10 Years
Min: -8.85   Med: -2.45   Max: 49.52
Current: -2.91

During the past 13 years, the highest Beneish M-Score of Semler Scientific was 49.52. The lowest was -8.85. And the median was -2.45.


Semler Scientific Beneish M-Score Historical Data

The historical data trend for Semler Scientific's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific Beneish M-Score Chart

Semler Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.52 -2.77 -2.29 -1.97 -1.98

Semler Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.12 -2.48 -1.61 -1.98 -2.91

Competitive Comparison of Semler Scientific's Beneish M-Score

For the Medical Devices subindustry, Semler Scientific's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Semler Scientific's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Semler Scientific's Beneish M-Score falls into.



Semler Scientific Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Semler Scientific for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6065+0.528 * 1.0346+0.404 * 0.6974+0.892 * 1.0822+0.115 * 0.7088
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8781+4.679 * -0.0376-0.327 * 0.5505
=-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $6.13 Mil.
Revenue was 15.903 + 15.057 + 16.316 + 18.605 = $65.88 Mil.
Gross Profit was 14.656 + 11.672 + 15.205 + 17.386 = $58.92 Mil.
Total Current Assets was $71.91 Mil.
Total Assets was $83.86 Mil.
Property, Plant and Equipment(Net PPE) was $2.72 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.65 Mil.
Selling, General, & Admin. Expense(SGA) was $29.93 Mil.
Total Current Liabilities was $5.90 Mil.
Long-Term Debt & Capital Lease Obligation was $0.05 Mil.
Net Income was 6.073 + 4.221 + 5.514 + 5.879 = $21.69 Mil.
Non Operating Income was 0.002 + -0.542 + -0.602 + -0.111 = $-1.25 Mil.
Cash Flow from Operations was 5.624 + 4.442 + 4.831 + 11.196 = $26.09 Mil.
Total Receivables was $9.34 Mil.
Revenue was 18.206 + 13.795 + 14.047 + 14.828 = $60.88 Mil.
Gross Profit was 16.937 + 12.613 + 12.909 + 13.865 = $56.32 Mil.
Total Current Assets was $55.59 Mil.
Total Assets was $70.26 Mil.
Property, Plant and Equipment(Net PPE) was $3.58 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.56 Mil.
Selling, General, & Admin. Expense(SGA) was $31.49 Mil.
Total Current Liabilities was $8.92 Mil.
Long-Term Debt & Capital Lease Obligation was $0.14 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6.132 / 65.881) / (9.343 / 60.876)
=0.093077 / 0.153476
=0.6065

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(56.324 / 60.876) / (58.919 / 65.881)
=0.925225 / 0.894325
=1.0346

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (71.905 + 2.72) / 83.856) / (1 - (55.592 + 3.576) / 70.257)
=0.110082 / 0.157835
=0.6974

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=65.881 / 60.876
=1.0822

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.563 / (0.563 + 3.576)) / (0.646 / (0.646 + 2.72))
=0.136023 / 0.191919
=0.7088

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(29.927 / 65.881) / (31.493 / 60.876)
=0.454258 / 0.51733
=0.8781

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.047 + 5.903) / 83.856) / ((0.138 + 8.918) / 70.257)
=0.070955 / 0.128898
=0.5505

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(21.687 - -1.253 - 26.093) / 83.856
=-0.0376

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Semler Scientific has a M-score of -2.91 suggests that the company is unlikely to be a manipulator.


Semler Scientific Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Semler Scientific's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Semler Scientific (Semler Scientific) Business Description

Traded in Other Exchanges
Address
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Executives
Eric Semler director 4625 FIELDSTON ROAD, BRONX NY 10471
Renae Cormier officer: Chief Financial Officer C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051
Douglas Murphy-chutorian director, 10 percent owner, officer: Chief Executive Officer C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Wayne T Pan director 2330 NW EVERETT STREET, PORTLAND OR 97210
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112
Chang 2020 Delaware Lp 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051
Arthur N Leibowitz director C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Chang 2020 Gp Llc 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051
Cindy Moon director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112
Daniel S Messina director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112
Daniel E Conger officer: Vice President, Finance C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
William H Chang 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Diana Shon Chang 10 percent owner 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002
Andrew B. Weinstein officer: Senior VP, Finance and Acct. C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Herbert J Semler director, 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210